출혈성 쇼크 치료 시장 : 약제, 유통 채널, 지역별 시장 규모, 점유율, 예측 - COVID-19의 영향 분석(2021-2027년)

※ 본 상품은 영문 자료로 한글과 영문목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계의 출혈성 쇼크 치료 시장 규모는 2019년까지 1억 8,030만 달러를 기록했으며, 2021-2027년 예측기간 중 4.4%의 CAGR로 확대될 전망입니다.

만성 질환이나 외상 증례 증가는 출혈성 쇼크 치료 시장 성장을 촉진합니다. 고혈압, 당뇨병, 만성 신부전, 만성 심장병, 만성 간질환 등의 상태는 출혈성 쇼크를 일으킬 가능성이 있습니다. 예를 들어 Health Affairs Organization에 의하면 2005년에는 1억 3,300만명 미국인이 적어도 1개의 만성 질환에 시달렸습니다. 이 수는 2020년에 1억 5,700만명으로 증가할 것으로 예측됩니다. 2005년에는 6,300만명이 다수의 만성 질환을 앓고, 2020년에는 8,100만명에 달할 것으로 예측됩니다. 당뇨병 유병률은 세계적으로 급증할 것으로 예상됩니다.

라이프스타일 변화, 유전자 변이나 영양실조 등 다양한 요인도 표적 시장 성장을 지지합니다. WHO에 의하면 2016년에는 160만명의 사인이 당뇨병에 직접 기인했습니다. 한편 2012년에는 220만명의 사인이 고혈당에 의한 것이었습니다. 또한 고령자는 출혈성 쇼크를 일으킬 위험이 높아지고 있습니다. WHO가 발표한 데이터에 의하면 세계의 고령자 인구는 2010년 5억 2,400만명에 대해 2050년까지 약 20억명(세계 인구의 22%)에 달할 가능성이 있습니다.

세계의 출혈성 쇼크 치료(Hemorrhagic Shock Treatment) 시장에 대해 조사 분석했으며, 시장 개요, 시장 규모와 예측, 부문별 시장 분석, 지역별 시장 분석, 경쟁 상황 등에 대한 체계적인 정보를 제공합니다.

목차

제1장 출혈성 쇼크 치료 시장 개요

제2장 주요 요약

• 시장 내역
  • 시장 내역 : 약제 종류별
  • 시장 내역 : 유통 채널별
  • 시장 내역 : 지역별
• 경쟁 분석

제3장 출혈성 쇼크 치료 주요 시장 동향

• 시장 성장 촉진요인
  • 시장 성장 촉진요인의 영향 분석
• 시장 성장 억제요인
  • 시장 성장 억제요인의 영향 분석
• 시장 기회
• 시장 향후 동향

제4장 출혈성 쇼크 치료 업계의 조사

• Porter's Five Forces 분석
• 마케팅 전략 분석
• 성장 전망 매핑
• 규제 체계 분석

제5장 출혈성 쇼크 치료 시장 : COVID-19의 영향 분석

• COVID-19 이전의 영향 분석
• COVID-19 이후의 영향 분석
  • 고실적 부문
  • 한계 성장 부문
  • 저실적 부문
  • 한계 손실 부문

제6장 출혈성 쇼크 치료 : 시장 상황

• 시장 점유율 분석
• 주요 이노베이터 분석
• 내역 데이터 : 주요 제조업체별
  • 기존 기업 분석
  • 신흥 기업 분석

제7장 출혈성 쇼크 치료 시장 : 약제 종류별

• 개요
• 부문 점유율 분석 : 약제 종류별
• NVX-408
• YW-356
• LB-1148
• Neutrolide

제8장 출혈성 쇼크 치료 시장 : 유통 채널별

• 개요
• 부문 점유율 분석 : 유통 채널별
• 소매 약국
• 병원 약국
• 온라인 채널

제9장 출혈성 쇼크 치료 시장 : 지역별

• 서론
• 부문 점유율 분석 : 지역별
• 북미
  • 개요
  • 주요 제조업체
  • 시장 규모와 예측 : 국가별
  • 시장 규모와 예측 : 약제 종류별
  • 시장 규모와 예측 : 유통 채널별
  • 미국
  • 캐나다
• 유럽
  • 개요
  • 주요 제조업체
  • 시장 규모와 예측 : 국가별
  • 시장 규모와 예측 : 약제 종류별
  • 시장 규모와 예측 : 유통 채널별
  • 독일
  • 이탈리아
  • 영국
  • 프랑스
  • 기타(RoE)
• 아시아태평양(APAC)
  • 개요
  • 주요 제조업체
  • 시장 규모와 예측 : 국가별
  • 시장 규모와 예측 : 약제 종류별
  • 시장 규모와 예측 : 유통 채널별
  • 인도
  • 중국
  • 일본
  • 한국
  • 기타 아시아태평양
• 라틴아메리카
  • 개요
  • 주요 제조업체
  • 시장 규모와 예측 : 국가별
  • 시장 규모와 예측 : 약제 종류별
  • 시장 규모와 예측 : 유통 채널별
  • 브라질
  • 멕시코
  • 아르헨티나
  • 기타 라틴아메리카
• 중동 및 아프리카
  • 개요
  • 주요 제조업체
  • 시장 규모와 예측 : 국가별
  • 시장 규모와 예측 : 약제 종류별
  • 시장 규모와 예측 : 유통 채널별
  • 사우디아라비아
  • UAE

제10장 주요 벤더 분석

• 경쟁 대시보드
• 기업 개요
  • Biomedica Management Corporation
  • F. Hoffmann-La Roche Ltd.
  • NuvOxPharma LLC
  • Leading BioSciences, Inc.
  • Boehringer Ingelheim International GmbH
  • Johnson & Johnson Services Inc.
  • Bristol-Myers Squibb Company
  • AstraZeneca
  • Daiichi Sankyo Company, Limited
  • Teva Pharmaceutical Industries Ltd.
  • Novartis AG
  • ZydusCadila
  • Amneal Pharmaceuticals LLC

제11장 애널리스트의 전방위적 전망

제12장 부록

List of Tables

• TABLE List of data sources
• TABLE Market drivers; Impact Analysis
• TABLE Market restraints; Impact Analysis
• TABLE Hemorrhagic Shock Treatment Market : Drug Types Snapshot (2019)
• TABLE Segment Dashboard; Definition and Scope, by Drug Types
• TABLE Global Hemorrhagic Shock Treatment Market , by Drug Types 2016-2027 (USD Million)
• TABLE Hemorrhagic Shock Treatment Market : Distribution Channel Snapshot (2019)
• TABLE Segment Dashboard; Definition and Scope, by Distribution Channel
• TABLE Global Hemorrhagic Shock Treatment Market , by Distribution Channel 2016-2027 (USD Million)
• TABLE Hemorrhagic Shock Treatment Market : Regional snapshot (2019)
• TABLE Segment Dashboard; Definition and Scope, by Region
• TABLE Global Hemorrhagic Shock Treatment Market , by Region 2016-2027 (USD Million)
• TABLE North America Hemorrhagic Shock Treatment Market , by Country, 2016-2027 (USD Million)
• TABLE North America Hemorrhagic Shock Treatment Market , by Drug Types, 2016-2027 (USD Million)
• TABLE North America Hemorrhagic Shock Treatment Market , by Distribution Channel, 2016-2027 (USD Million)
• TABLE Europe Hemorrhagic Shock Treatment Market , by Country, 2016-2027 (USD Million)
• TABLE Europe Hemorrhagic Shock Treatment Market , by Drug Types, 2016-2027 (USD Million)
• TABLE Europe Hemorrhagic Shock Treatment Market , by Distribution Channel, 2016-2027 (USD Million)
• TABLE Asia Pacific Hemorrhagic Shock Treatment Market , by Country, 2016-2027 (USD Million)
• TABLE Asia Pacific Hemorrhagic Shock Treatment Market , by Drug Types, 2016-2027 (USD Million)
• TABLE Asia Pacific Hemorrhagic Shock Treatment Market , by Distribution Channel, 2016-2027 (USD Million)
• TABLE Latin America Hemorrhagic Shock Treatment Market , by Country, 2016-2027 (USD Million)
• TABLE Latin America Hemorrhagic Shock Treatment Market , by Drug Type, 2016-2027 (USD Million)
• TABLE Latin America Hemorrhagic Shock Treatment Market , by Distribution Channel, 2016-2027 (USD Million)
• TABLE Middle East and Africa Hemorrhagic Shock Treatment Market , by Country, 2016-2027 (USD Million)
• TABLE Middle East and Africa Hemorrhagic Shock Treatment Market , by Drug Type, 2016-2027 (USD Million)
• TABLE Middle East and Africa Hemorrhagic Shock Treatment Market , by Distribution Channel, 2016-2027 (USD Million)

List of Figures

• FIGURE Hemorrhagic Shock Treatment Market segmentation
• FIGURE Market research methodology
• FIGURE Value chain analysis
• FIGURE Porter's Five Forces Analysis
• FIGURE Market Attractiveness Analysis
• FIGURE COVID-19 Impact Analysis
• FIGURE Pre & Post COVID-19 Impact Comparision Study
• FIGURE Competitive Landscape; Key company market share analysis, 2019
• FIGURE Drug Type segment market share analysis, 2020 & 2027
• FIGURE Drug Type segment market size forecast and trend analysis, 2016 to 2027 (USD Million)
• FIGURE Distribution Channel segment market share analysis, 2020 & 2027
• FIGURE Distribution Channel segment market size forecast and trend analysis, 2016 to 2027 (USD Million)
• FIGURE Regional segment market share analysis, 2020 & 2027
• FIGURE Regional segment market size forecast and trend analysis, 2016 to 2027 (USD Million)
• FIGURE North America Hemorrhagic Shock Treatment Market share and leading players, 2019
• FIGURE Europe Hemorrhagic Shock Treatment Market share and leading players, 2019
• FIGURE Asia Pacific Hemorrhagic Shock Treatment Market share and leading players, 2019
• FIGURE Latin America Hemorrhagic Shock Treatment Market share and leading players, 2019
• FIGURE Middle East and Africa Hemorrhagic Shock Treatment Market share and leading players, 2019
• FIGURE North America market share analysis by country, 2019
• FIGURE U.S. Hemorrhagic Shock Treatment Market size, forecast and trend analysis, 2016 to 2027 (USD Million)
• FIGURE Canada Hemorrhagic Shock Treatment Market size, forecast and trend analysis, 2016 to 2027 (USD Million)
• FIGURE Europe Hemorrhagic Shock Treatment Market share analysis by country, 2019
• FIGURE Germany Hemorrhagic Shock Treatment Market size, forecast and trend analysis, 2016 to 2027 (USD Million)
• FIGURE Spain Hemorrhagic Shock Treatment Market size, forecast and trend analysis, 2016 to 2027 (USD Million)
• FIGURE Italy Hemorrhagic Shock Treatment Market size, forecast and trend analysis, 2016 to 2027 (USD Million)
• FIGURE UK Hemorrhagic Shock Treatment Market size, forecast and trend analysis, 2016 to 2027 (USD Million)
• FIGURE France Hemorrhagic Shock Treatment Market size, forecast and trend analysis, 2016 to 2027 (USD Million)
• FIGURE Rest of the Europe Hemorrhagic Shock Treatment Market size, forecast and trend analysis, 2016 to 2027 (USD Million)
• FIGURE Asia Pacific Hemorrhagic Shock Treatment Market share analysis by country, 2019
• FIGURE India Hemorrhagic Shock Treatment Market size, forecast and trend analysis, 2016 to 2027 (USD Million)
• FIGURE China Hemorrhagic Shock Treatment Market size, forecast and trend analysis, 2016 to 2027 (USD Million)
• FIGURE Japan Hemorrhagic Shock Treatment Market size, forecast and trend analysis, 2016 to 2027 (USD Million)
• FIGURE South Korea Hemorrhagic Shock Treatment Market size, forecast and trend analysis, 2016 to 2027 (USD Million)
• FIGURE Singapore Hemorrhagic Shock Treatment Market size, forecast and trend analysis, 2016 to 2027 (USD Million)
• FIGURE Rest of APAC Hemorrhagic Shock Treatment Market size, forecast and trend analysis, 2016 to 2027 (USD Million)
• FIGURE Latin America Hemorrhagic Shock Treatment Market size, forecast and trend analysis, 2016 to 2027 (USD Million)
• FIGURE Latin America Hemorrhagic Shock Treatment Market share analysis by country, 2019
• FIGURE Brazil Hemorrhagic Shock Treatment Market size, forecast and trend analysis, 2016 to 2027 (USD Million)
• FIGURE Mexico Hemorrhagic Shock Treatment Market size, forecast and trend analysis, 2016 to 2027 (USD Million)
• FIGURE Argentina Hemorrhagic Shock Treatment Market size, forecast and trend analysis, 2016 to 2027 (USD Million)
• FIGURE Rest of LATAM Hemorrhagic Shock Treatment Market size, forecast and trend analysis, 2016 to 2027 (USD Million)
• FIGURE Middle East and Africa Hemorrhagic Shock Treatment Market size, forecast and trend analysis, 2016 to 2027 (USD Million)
• FIGURE Middle East and Africa Hemorrhagic Shock Treatment Market share analysis by country, 2019
• FIGURE Saudi Arabia Hemorrhagic Shock Treatment Market size, forecast and trend analysis, 2016 to 2027 (USD Million)
• FIGURE United Arab Emirates Hemorrhagic Shock Treatment Market size, forecast and trend analysis, 2016 to 2027 (USD Million)

REPORT HIGHLIGHT

The global hemorrhagic shock treatment market was valued at USD 180.3 million by 2019, growing with 4.4% CAGR during the forecast period, 2021-2027.

Hemorrhagic shock occurs when there are large amounts of blood loss in the body. People suffering from injuries that involve heavy blood loss may go into hemorrhagic shock if the bleeding doesn't stop immediately. Blood carries oxygen and other essential constituents to our tissues and organs. When extensive blooding occurs, these constituents are lost more quickly. Growing cases of chronic diseases and trauma drives the growth of the hemorrhagic shock treatment market. Conditions such as hypertension, diabetes, chronic renal failure, chronic heart disease, and chronic liver disease can cause hemorrhagic shock. For instance, according to the Health Affairs Organization, in 2005, 133 million Americans were suffering from at least one chronic condition. This number is projected to grow to 157 million in 2020. In 2005, 63 million people had multiple chronic illnesses, and that number will reach 81 million in 2020. The increasing prevalence of diabetes is anticipated to surge exponentially, across the globe.

Changes in lifestyle and various other factors such as genetic mutations and malnutrition also boost the growth of the target market. According to WHO, 1.6 million deaths were directly caused by diabetes in 2016. Whereas, 2.2 million deaths were due to high blood glucose in 2012. Diabetes is measured as a leading fatal disease. Diabetes estimates for nearly 71,000 deaths in the U.S. every year. About 1 in 11 adults in the country suffers from diabetes, according to the American Diabetes Association. Various government and private organizations are operating in the diabetes industry to create awareness among people. Geriatric people are at a high risk to cause hemorrhagic shock. According to data published by WHO, the overall geriatric population is likely to reach around 2 billion (22% of the global population) by 2050, as compared to 524 million in 2010. In addition, the geriatric population across the globe is expected to rise at a rapid pace in developed countries such as the U.S., the U.K., and Japan. Wherein, countries such as China, Brazil, Thailand, and South Korea are estimated to have a large geriatric population base in the shortest span of time over the forecast period.

Companies in the hemorrhagic shock treatment market are involved in the research & d development of therapies and drugs for the treatment of hemorrhagic shock. For instance, in July 2020, Pharmazz, Inc., a biopharmaceutical company focused on the development of effective therapeutics to treat patients in critical care, announced that it has received marketing authorization of Lyfaquin (centhaquine). Lyfaquin is a novel resuscitative agent indicated for the treatment of patients with hypovolemic shock as a primary adjuvant to the standard of care.

Key features of the study:

• This proposed research study on Hemorrhagic Shock Treatment market provides market size (US$ million), compound annual growth rate (CAGR %) and forecast estimation (2020-2027), considering 2019 as the base year

• The research report elucidates potential growth opportunities across different segments/countries and explains attractive investment proposition matrix for Hemorrhagic Shock Treatment market

• The overall report identifies new investment opportunities, challenges faced by established players, and growth factors to sustain in the Hemorrhagic Shock Treatment market

• Impact of COVID-19 on Hemorrhagic Shock Treatment market size, forecast, CAGR, and market dynamics are discussed in detail under the research scope. Detailed insight on Hemorrhagic Shock Treatment market post-COVID will also be covered.

• In order to give the users of this report a comprehensive view on the Hemorrhagic Shock Treatment market, we have also included competitive landscape and key innovator analysis for the Hemorrhagic Shock Treatment market.

• The study encompasses a growth prospect mapping analysis, wherein all the industry segments are benchmarked based on their market size, growth rate and Distribution Channel's attractiveness.

• The report offers detailed company profiling featuring major market participants which will help users to understand their financial information and strategic initiatives of players operating in the Hemorrhagic Shock Treatment market.

• In addition, the report also unveil the important acquisitions & mergers, collaborations & joint ventures, new product launch, research & development, regional expansion of major participants involved in the Hemorrhagic Shock Treatment market on global as well as regional level.

• The global Hemorrhagic Shock Treatment market report primarily caters to various stakeholders in this industry including suppliers, investors, new entrants, distributors, and financial analysts

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL HEMORRHAGIC SHOCK TREATMENT MARKET KEY PLAYERS

• Biomedica Management Corporation
• F. Hoffmann-La Roche Ltd.
• NuvOxPharma LLC
• Leading BioSciences, Inc.
• Boehringer Ingelheim International GmbH
• Johnson & Johnson Services Inc.
• Bristol-Myers Squibb Company
• AstraZeneca
• Daiichi Sankyo Company, Limited
• Teva Pharmaceutical Industries Ltd.
• Novartis AG
• ZydusCadila
• Amneal Pharmaceuticals LLC

GLOBAL HEMORRHAGIC SHOCK TREATMENT MARKET, BY DRUG

• NVX-408
• YW-356
• LB-1148
• Neutrolide
• Others

GLOBAL HEMORRHAGIC SHOCK TREATMENT MARKET, BY DISTRIBUTION CHANNEL

• Retail Pharmacy
• Hospital Pharmacy
• Online Channels

GLOBAL HEMORRHAGIC SHOCK TREATMENT MARKET, BY REGION

• North America
  • The U.S.
  • Canada

• Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Rest of Europe

• Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Singapore
  • Rest of APAC

• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of LATAM

• The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Rest of MEA

Table of Contents

1. Hemorrhagic Shock Treatment Market Overview

• Study Scope

2. Executive Summary

• Market Snippet
• Market Snippet by Drug Type
• Market Snippet by Distribution Channel
• Market Snippet by Region
• Competitive Insights

3. Hemorrhagic Shock Treatment Key Market Trends

• Market Drivers
• Impact Analysis of Market Drivers
• Market Restraints
• Impact Analysis of Market Restraints
• Market Opportunities
• Market Future Trends

4. Hemorrhagic Shock Treatment Industry Study

• Porter's Five Forces Analysis
• Marketing Strategy Analysis
• Growth Prospect Mapping
• Regulatory Framework Analysis

5. Hemorrhagic Shock Treatment Market : COVID-19 Impact Analysis

• Pre-COVID-19 Impact Analysis
• Post-COVID-19 Impact Analysis
• Top Performing Segments
• Marginal Growth Segments
• Top Looser Segments
• Marginal Loss Segments

6. Hemorrhagic Shock Treatment Market Landscape

• Market Share Analysis, 2019
• Key Innovators Analysis
• Breakdown Data, by Key Manufacturer
• Established Players' Analysis
• Emerging Players' Analysis

7. Hemorrhagic Shock Treatment Market - By Drug Type

• Overview
• Segment Share Analysis, By Drug Type, 2020 & 2027 (%)
• NVX-408
• YW-356
• LB-1148
• Neutrolide
• Others

8. Hemorrhagic Shock Treatment Market - By Distribution Channel

• Overview
• Segment Share Analysis, By Distribution Channel, 2020 & 2027 (%)
• Retail Pharmacy
• Hospital Pharmacy
• Online Channels

9. Hemorrhagic Shock Treatment Market - By Geography

• Introduction
• Segment Share Analysis, By Geography, 2020 & 2027 (%)
• North America
• Overview
• Key Manufacturers in North America
• North America Market Size and Forecast, By Country, 2016 - 2027 (US$ Million)
• North America Market Size and Forecast, By Drug Type, 2016 - 2027 (US$ Million)
• North America Market Size and Forecast, By Distribution Channel, 2016 - 2027 (US$ Million)
• U.S.
• Overview
• Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
• U.S. Market Size and Forecast, By Drug Type, 2016 - 2027 (US$ Million)
• U.S. Market Size and Forecast, By Distribution Channel, 2016 - 2027 (US$ Million)
• Canada
• Overview
• Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
• Canada Market Size and Forecast, By Drug Type, 2016 - 2027 (US$ Million)
• Canada Market Size and Forecast, By Distribution Channel, 2016 - 2027 (US$ Million)
• Europe
• Overview
• Key Manufacturers in Europe
• Europe Market Size and Forecast, By Country, 2016 - 2027 (US$ Million)
• Europe Market Size and Forecast, By Drug Type, 2016 - 2027 (US$ Million)
• Europe Market Size and Forecast, By Distribution Channel, 2016 - 2027 (US$ Million)
• Germany
• Overview
• Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
• Germany Market Size and Forecast, By Drug Type, 2016 - 2027 (US$ Million)
• Germany Market Size and Forecast, By Distribution Channel, 2016 - 2027 (US$ Million)
• Italy
• Overview
• Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
• Italy Market Size and Forecast, By Drug Type, 2016 - 2027 (US$ Million)
• Italy Market Size and Forecast, By Distribution Channel, 2016 - 2027 (US$ Million)
• United Kingdom
• Overview
• Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
• United Kingdom Market Size and Forecast, By Drug Type, 2016 - 2027 (US$ Million)
• United Kingdom Market Size and Forecast, By Distribution Channel, 2016 - 2027 (US$ Million)
• France
• Overview
• Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
• France Market Size and Forecast, By Drug Type, 2016 - 2027 (US$ Million)
• France Market Size and Forecast, By Distribution Channel, 2016 - 2027 (US$ Million)
• Rest of Europe
• Overview
• Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
• Rest of the Europe Market Size and Forecast, By Drug Type, 2016 - 2027 (US$ Million)
• Rest of the Europe Market Size and Forecast, By Distribution Channel, 2016 - 2027 (US$ Million)
• Asia Pacific (APAC)
• Overview
• Key Manufacturers in Asia Pacific
• Asia Pacific Market Size and Forecast, By Country, 2016 - 2027 (US$ Million)
• Asia Pacific Market Size and Forecast, By Drug Type, 2016 - 2027 (US$ Million)
• Asia Pacific Market Size and Forecast, By Distribution Channel, 2016 - 2027 (US$ Million)
• India
• Overview
• Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
• India Market Size and Forecast, By Drug Type, 2016 - 2027 (US$ Million)
• India Market Size and Forecast, By Distribution Channel, 2016 - 2027 (US$ Million)
• China
• Overview
• Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
• China Market Size and Forecast, By Drug Type, 2016 - 2027 (US$ Million)
• China Market Size and Forecast, By Distribution Channel, 2016 - 2027 (US$ Million)
• Japan
• Overview
• Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
• Japan Market Size and Forecast, By Drug Type, 2016 - 2027 (US$ Million)
• Japan Market Size and Forecast, By Distribution Channel, 2016 - 2027 (US$ Million)
• South Korea
• Overview
• Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
• South Korea Market Size and Forecast, By Drug Type, 2016 - 2027 (US$ Million)
• South Korea Market Size and Forecast, By Distribution Channel, 2016 - 2027 (US$ Million)
• Rest of APAC
• Overview
• Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
• Rest of APAC Market Size and Forecast, By Drug Type, 2016 - 2027 (US$ Million)
• Rest of APAC Market Size and Forecast, By Distribution Channel, 2016 - 2027 (US$ Million)
• Latin America
• Overview
• Key Manufacturers in Latin America
• Latin America Market Size and Forecast, By Country, 2016 - 2027 (US$ Million)
• Latin America Market Size and Forecast, By Drug Type, 2016 - 2027 (US$ Million)
• Latin America Market Size and Forecast, By Distribution Channel, 2016 - 2027 (US$ Million)
• Brazil
• Overview
• Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
• Brazil Market Size and Forecast, By Drug Type, 2016 - 2027 (US$ Million)
• Brazil Market Size and Forecast, By Distribution Channel, 2016 - 2027 (US$ Million)
• Mexico
• Overview
• Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
• Mexico Market Size and Forecast, By Drug Type, 2016 - 2027 (US$ Million)
• Mexico Market Size and Forecast, By Distribution Channel, 2016 - 2027 (US$ Million)
• Argentina
• Overview
• Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
• Argentina Market Size and Forecast, By Drug Type, 2016 - 2027 (US$ Million)
• Argentina Market Size and Forecast, By Distribution Channel, 2016 - 2027 (US$ Million)
• Rest of LATAM
• Overview
• Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
• Rest of LATAM Market Size and Forecast, By Drug Type, 2016 - 2027 (US$ Million)
• Rest of LATAM Market Size and Forecast, By Distribution Channel, 2016 - 2027 (US$ Million)
• Middle East and Africa
• Overview
• Key Manufacturers in Middle East and Africa
• Middle East and Africa Market Size and Forecast, By Country, 2016 - 2027 (US$ Million)
• Middle East and Africa Market Size and Forecast, By Drug Type, 2016 - 2027 (US$ Million)
• Middle East and Africa Market Size and Forecast, By Distribution Channel, 2016 - 2027 (US$ Million)
• Saudi Arabia
• Overview
• Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
• Saudi Arabia Market Size and Forecast, By Drug Type, 2016 - 2027 (US$ Million)
• Saudi Arabia Market Size and Forecast, By Distribution Channel, 2016 - 2027 (US$ Million)
• United Arab Emirates
• Overview
• Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
• United Arab Emirates Market Size and Forecast, By Drug Type, 2016 - 2027 (US$ Million)
• United Arab Emirates Market Size and Forecast, By Distribution Channel, 2016 - 2027 (US$ Million)

10. Key Vendor Analysis

• Competitive Dashboard
• Company Profiles( Companies are profiled based on attributes such as Company Overview, Financial Performance, Business Overview, Product Benchmarking and Strategic Developments)
• Biomedica Management Corporation
• F. Hoffmann-La Roche Ltd.
• NuvOxPharma LLC
• Leading BioSciences, Inc.
• Boehringer Ingelheim International GmbH
• Johnson & Johnson Services Inc.
• Bristol-Myers Squibb Company
• AstraZeneca
• Daiichi Sankyo Company, Limited
• Teva Pharmaceutical Industries Ltd.
• Novartis AG
• ZydusCadila
• Amneal Pharmaceuticals LLC

11. 360 Degree Analyst View

12. Appendix

• Research Methodology
• References
• Abbreviations
• Disclaimer
• Contact Us